Table A2.
Primary Cancer Type
| Cancer Type | CCS Code* | White (n = 4,062), % | African American (n = 1,089), % | Hispanic (n = 334), % |
|---|---|---|---|---|
| Head and neck | 11 | 2.8 | 1.6 | 0.9 |
| Esophagus | 12 | 1.0 | 0.6 | 0.3 |
| Stomach | 13 | 1.0 | 1.9 | 2.4 |
| Colon | 14 | 4.6 | 7.4 | 5.1 |
| Rectum and anus | 15 | 1.9 | 2.4 | 2.1 |
| Liver and intrahepatic bile duct | 16 | 2.2 | 1.7 | 3.3 |
| Pancreas | 17 | 2.3 | 3.1 | 2.4 |
| Other GI organs and peritoneum | 18 | 1.5 | 1.5 | 3.0 |
| Bronchus and lung | 19 | 7.6 | 8.6 | 3.6 |
| Other respiratory/intrathoracic | 20 | 0.05 | 0.2 | 0 |
| Bone and connective tissue | 21 | 1.2 | 0.9 | 2.1 |
| Melanoma | 22 | 1.7 | 0.09 | 0 |
| Other nonepithelial skin cancer | 23 | 2.0 | 0.6 | 0.9 |
| Breast | 24 | 13.8 | 17.2 | 12.6 |
| Uterus | 25 | 2.0 | 3.9 | 3.0 |
| Cervix | 26 | 0.7 | 0.8 | 0 |
| Ovary | 27 | 3.1 | 2.4 | 2.4 |
| Other female genital organs | 28 | 0.5 | 0.7 | 0.6 |
| Prostate | 29 | 4.0 | 5.6 | 2.1 |
| Testis | 30 | 0.3 | 0 | 0.6 |
| Other male genital organs | 31 | 0.05 | 0 | 0 |
| Bladder | 32 | 1.9 | 1.2 | 0.6 |
| Kidney and renal pelvis | 33 | 2.0 | 1.7 | 3.6 |
| Other urinary organs | 34 | 0.15 | 0.2 | 0 |
| Brain and nervous system | 35 | 1.2 | 0.4 | 2.1 |
| Thyroid | 36 | 1.7 | 1.0 | 2.7 |
| Hodgkin disease | 37 | 2.2 | 1.9 | 3.0 |
| Non-Hodgkin lymphoma | 38 | 9.7 | 7.0 | 12.9 |
| Leukemia | 39 | 8.4 | 4.5 | 8.4 |
| Multiple myeloma | 40 | 7.2 | 8.5 | 7.8 |
| Other and unspecified primary | 41 | 10.9 | 11.9 | 10.8 |
Abbreviation: CCS, Clinical Classification Software Codes.
*
CCS clusters International Classification of Diseases, 9th Revision, Clinical Modification diagnosis codes into broader categories of cancer type (additional details can be found at https://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccsfactsheet.jsp).